류코트리엔과 알레르기 염증

키워드

참고문헌 (46)

1. National Asthma Education and Prevention Program Institute, Expert panel report 3: guidelines for the diagnosis and management of asthma, "National Institutes of Health: National Heart, Lung, and Blood", ~, pp.No. 07-4051 (2007)
2. Peters-Golden M, "Leukotrienes", N Engl J Med, 357, pp.1841~1854 (2007)
3. Gyllfors P, "Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate", Allergy Clin Immunol, 118, pp.78~83 (2006)
4. Drazen JM, "Treatment of asthma with drugs modifying the leukotriene pathway", N Engl J Med, 340, pp.197~206 (1999)
5. Peters-Golden M, "5-lipoxygenase and FLAP", Prostaglandins Leukot Essent Fatty Acids, 69, pp.99~109 (2003)
6. Mandal AK, "The nuclear membrane organization of leukotriene synthesis", Proc Natl Acad Sci U S A, 105, pp.20434~20439 (2008)
7. Zarini S, "Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation", Proc Natl Acad Sci U S A, 106, pp.8296~8301 (2009)
8. Lam BK, "The mechanism of leukotriene B4 export from human polymorphonuclear leukocytes", J Biol Chem, 265, pp.13438~13441 (1990)
9. Lam BK, "The identification of a distinct export step following the biosynthesis of leukotriene C4 by human eosinophils", J Biol Chem, 264, pp.12885~12889 (1989)
10. Reid G, "The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs", Proc Natl Acad Sci U S A, 100, pp.9244~9249 (2003)
11. Rius M, "ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4)", J Pharmacol Exp Ther, 324, pp.86~94 (2008)
12. Davidson AB, "Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects", Am Rev Respir Dis, 135, pp.333~337 (1987)
13. Gauvreau GM, "Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma", Am J Respir Crit Care Med, 164, pp.1495~1500 (2001)
14. Maekawa A, "Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors", Proc Natl Acad Sci U S A, 105, pp.16695~16700 (2008)
15. Paruchuri S, "Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor", J Exp Med, 206, pp.2543~2555 (2009)
16. Thivierge M, "IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages", J Immunol, 167, pp.2855~2860 (2001)
17. Sousa AR, "Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis", N Engl J Med, 347, pp.1493~1499 (2002)
18. Kim DC, "Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation", J Immunol, 176, pp.4440~4448 (2006)
19. Lex C, "Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study", Respir Res, 7, pp.63~ (2006)
20. Hallstrand TS, "An update on the role of leukotrienes in asthma", Curr Opin Allergy Clin Immunol, 10, pp.60~66 (2010)
21. Henderson WR Jr, "A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model", Am J Respir Crit Care Med, 165, pp.108~116 (2002)
22. Parameswaran K, "Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines", Am J Respir Cell Mol Biol, 37, pp.240~247 (2007)
23. Carraro S, "Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction", J Allergy Clin Immunol, 115, pp.764~770 (2005)
24. Pearlman DS, "Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast", Ann Allergy Asthma Immunol, 97, pp.98~104 (2006)
25. Beller TC, "Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin- induced pulmonary fibrosis in mice", J Biol Chem, 279, pp.46129~46134 (2004)
26. Laitinen A, "Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma", J Allergy Clin Immunol, 115, pp.259~265 (2005)
27. Islam SA, "The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans", Blood, 107, pp.444~453 (2006)
28. Weller CL, "Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors", J Exp Med, 201, pp.1961~1971 (2005)
29. Terawaki K, "Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses", J Immunol, 175, pp.4217~4225 (2005)
30. Ohnishi H, "Corticosteroids enhance CD8+ T cell-mediated airway hyperresponsiveness and allergic inflammation by upregulating leukotriene B4 receptor 1", J Allergy Clin Immunol, 121, pp.864~871 (2008)
31. Ohnishi H, "The role of leukotriene B(4) in allergic diseases", Allergol Int, 57, pp.291~298 (2008)
32. Okunishi K, "Leukotrienes and airway inflammation", Biochim Biophys Acta, 1810, pp.1096~1102 (2011)
33. Cho KJ, "Blockade of airway inflammation and hyperresponsiveness by inhibition of BLT2, a low-affinity leukotriene B4 receptor", Am J Respir Cell Mol Biol, 42, pp.294~303 (2010)
34. Busse W, "Fluticasone Proprionate Clinical Research Study Group. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial", J Allergy Clin Immunol, 107, pp.461~468 (2001)
35. Drazen JM, "Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment", Nat Genet, 22, pp.168~170 (1999)
36. Sayers I, "Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma", Thorax, 58, pp.417~424 (2003)
37. Kawagishi Y, "Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma", J Allergy Clin Immunol, 109, pp.936~942 (2002)
38. Hasday JD, "Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics", Am J Respir Crit Care Med, 161, pp.1229~1236 (2000)
39. 김미경, "Genetic effect of CysLTR2 polymorphisms on its mRNA synthesis and stabilization", BMC GENETICS, 10, pp.106~117, BIOMED CENTRAL LTD
40. Tomari S, "Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists", Respiration, 76, pp.398~402 (2008)
41. Gaber F, "Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma", Thorax, 63, pp.1076~1082 (2008)
42. 박춘식, "Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics", Allergy, Asthma & Immunology Research, 2(1), pp.48~54 (2010), 대한천식알레르기학회
43. Stelmach I, "Effect of different antiasthmatic treatments on exercise- induced bronchoconstriction in children with asthma", J Allergy Clin Immunol, 121, pp.383~389 (2008)
44. Covar RA, "Progression of asthma measured by lung function in the childhood asthma management program", Am J Respir Crit Care Med, 170, pp.234~241 (2004)
45. Henderson WR Jr, "Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade", Am J Respir Crit Care Med, 173, pp.718~728 (2006)
46. Brozek JL, "Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision", J Allergy Clin Immunol, 126, pp.466~476 (2010)

관련 논문AI추천